Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q3MHW9

Entry ID Method Resolution Chain Position Source
AF-Q3MHW9-F1 Predicted AlphaFoldDB

105 variants for Q3MHW9

Variant ID(s) Position Change Description Diseaes Association Provenance
rs458119861 6 S>G No EVA
rs478108188 7 P>R No EVA
rs450023221 8 V>G No EVA
rs480621233 16 G>E No EVA
rs470184460 16 G>R No EVA
rs449502829 17 L>M No EVA
rs466442937 18 L>V No EVA
rs445454760 22 G>S No EVA
rs436876684 27 A>T No EVA
rs456989435 27 A>V No EVA
rs137388115 28 Y>S No EVA
rs435943903 29 L>R No EVA
rs453140494 30 V>A No EVA
rs473320465 32 R>G No EVA
rs438609033 33 S>A No EVA
rs438609033 33 S>P No EVA
rs443712616 34 R>L No EVA
rs475372089 34 R>S No EVA
rs449256425 36 P>S No EVA
rs480086973 41 L>M No EVA
rs445491801 42 D>A No EVA
rs465581890 44 N>T No EVA
rs450505547 45 E>G No EVA
rs437367677 45 E>Q No EVA
rs450505547 45 E>V No EVA
rs436028403 47 Y>* No EVA
rs467452382 47 Y>S No EVA
rs452870564 48 Q>H No EVA
rs432236728 49 L>Q No EVA
rs473137033 49 L>V No EVA
rs452262877 51 L>P No EVA
rs452262877 51 L>R No EVA
rs444179243 53 D>A No EVA
rs463857635 54 K>Q No EVA
rs461560767 56 T>A No EVA
rs461560767 56 T>S No EVA
rs481675656 62 K>R No EVA
rs476882102 72 H>D No EVA
rs462397510 75 L>M No EVA
rs450060419 81 K>N No EVA
rs480935525 86 S>A No EVA
rs449566981 87 A>T No EVA
rs434927340 94 V>A No EVA
rs465056995 96 R>S No EVA
rs436824544 98 Y>C No EVA
rs456899474 99 T>A No EVA
rs467679655 99 T>I No EVA
rs436267779 103 S>I No EVA
rs453062369 105 E>G No EVA
rs471611047 163 I>S No EVA
rs463039848 175 V>M No EVA
rs448457840 181 M>R No EVA
rs462000532 183 A>G No EVA
rs474479590 189 T>I No EVA
rs459955314 190 P>S No EVA
rs481531130 217 E>D No EVA
rs446913451 218 K>T No EVA
rs466935343 222 L>* No EVA
rs432318209 231 A>V No EVA
rs452767880 233 H>P No EVA
rs469508808 233 H>Q No EVA
rs452767880 233 H>R No EVA
rs438190709 239 L>R No EVA
rs454987618 241 F>V No EVA
rs474979332 242 T>P No EVA
rs470611142 245 H>R No EVA
rs462881024 246 P>H No EVA
rs439184212 246 P>T No EVA
rs442029028 250 W>S No EVA
rs462158260 251 A>G No EVA
rs479020792 252 Y>D No EVA
rs441518690 253 S>I No EVA
rs458360027 254 K>N No EVA
rs478428781 256 F>V No EVA
rs450308102 257 V>G No EVA
rs463488450 264 E>D No EVA
rs480318138 266 L>Q No EVA
rs435772448 268 A>T No EVA
rs448857715 273 V>A No EVA
rs434365657 274 L>P No EVA
rs456983584 281 P>H No EVA
rs435673586 283 M>I No EVA
rs472667148 284 V>G No EVA
rs455719544 284 V>L No EVA
rs441166803 285 Q>P No EVA
rs458495519 286 L>P No EVA
rs458495519 286 L>R No EVA
rs472076482 287 A>P No EVA
rs443900017 288 C>G No EVA
rs480784261 289 H>R No EVA
rs463978550 289 H>Y No EVA
rs449007021 290 P>R No EVA
rs459359258 292 L>M No EVA
rs479508815 292 L>R No EVA
rs459359258 292 L>V No EVA
rs444785371 294 K>I No EVA
rs464755665 295 L>M No EVA
rs437061815 295 L>R No EVA
rs450670798 297 Y>C No EVA
rs467417234 298 S>* No EVA
rs455845240 300 K>T No EVA
rs472674783 301 M>L No EVA
rs434816002 302 R>G No EVA
rs451730848 302 R>L No EVA
rs471742452 305 Y>D No EVA

No associated diseases with Q3MHW9

3 regional properties for Q3MHW9

Type Name Position InterPro Accession
domain Cyclin, C-terminal domain 188 - 310 IPR004367
domain Cyclin, N-terminal 84 - 185 IPR006671
domain Cyclin-like domain 91 - 179 IPR013763

Functions

Description
EC Number 1.6.2.2 With a heme protein as acceptor
Subcellular Localization
  • Membrane ; Single-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

2 GO annotations of molecular function

Name Definition
cytochrome-b5 reductase activity, acting on NAD(P)H Catalysis of the reaction: NAD(P)H + H+ + 2 ferricytochrome b(5) = NAD(P)+ + 2 ferrocytochrome b(5).
FAD binding Binding to the oxidized form, FAD, of flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.

1 GO annotations of biological process

Name Definition
sterol biosynthetic process The chemical reactions and pathways resulting in the formation of sterols, steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q96HP4 OXNAD1 Oxidoreductase NAD-binding domain-containing protein 1 Homo sapiens (Human) PR
Q9UHQ9 CYB5R1 NADH-cytochrome b5 reductase 1 Homo sapiens (Human) PR
Q9DB73 Cyb5r1 NADH-cytochrome b5 reductase 1 Mus musculus (Mouse) PR
Q5EB81 Cyb5r1 NADH-cytochrome b5 reductase 1 Rattus norvegicus (Rat) PR
Q9ZNT1 CBR1 NADH--cytochrome b5 reductase 1 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MGLQPSPVLL ASLGVGLLTL LGVALGAYLV RRSRRPPVTL LDPNEKYQLR LLDKTTVNHN
70 80 90 100 110 120
TKRFRFALPT AHHVLGLPVG KHVYLSARID GSLVIRPYTP VTSDEDQGYV DLVIKVYLKG
130 140 150 160 170 180
VHPKFPEGGK MSQYLDSLKI GDVVEFRGPS GLLTYAGKGK FNIQPNKKAP PEARVARNLG
190 200 210 220 230 240
MIAGGTGITP MLQLIRAILK DPEDPTQCFL LFANQTEKDI ILREDLEELQ ARHPGRFKLW
250 260 270 280 290 300
FTLDHPPEGW AYSKGFVSVD MIREHLPAPG EDVLLLLCGP PPMVQLACHP SLDKLGYSPK
MRFTY